Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 15284741.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The purpose of this study was to codify the relationship between bacterial vaginosis/fetal fibronectin and preterm labor/birth. In this prospective study, 185 women who were symptomatic for preterm labor were assessed for bacterial vaginosis and fetal fibronectin. These women comprised 4 groups: group A (n=23 women; +bacterial vaginosis/+fetal fibronectin); group B (n=31 women; -bacterial vaginosis/+fetal fibronectin); group C (n=47 women; +bacterial vaginosis/-fetal fibronectin); and group D (n=84 women; -bacterial vaginosis/-fetal fibronectin). The time interval from gestational age at testing until delivery was significantly shorter for groups A and B versus groups C and D (P < or =.05 and P <.001, respectively). Similarly, delivery at <32 weeks of gestation was increased in group B (26%) compared with groups A (9%), C (2%), and D (5%; P <.009; odds ratio, 165.90; 95% CI, 30.02, 916.08). Women who are symptomatic for preterm labor should be considered for fetal fibronectin and bacterial vaginosis testing.
Medical subject headings
- Fibronectins
- Glycoproteins
- Obstetric Labor, Premature
- Pregnancy Complications, Infectious
- Pregnancy Outcome
- Vaginosis, Bacterial